Title: (Reprinted with amendments adopted on May 19, 2025)
Official Title: (Reprinted with amendments adopted on May 19, 2025)
Number of Sections: 1
Source: versions - Reprint 1
Media Type: application/pdf
Strikethrough Detection: 2 sections found

================================================================================

Section 1:
FIRST REPRINT A.B. 411
ASSEMBLY BILL NO. 411–ASSEMBLYMEMBER JAUREGUI
MARCH 12, 2025
____________
Referred to Committee on Health and Human Services
SUMMARY—Revises provisions relating to prescription drugs.
(BDR 54-1100)
FISCAL NOTE: Effect on Local Government: No.
Effect on the State: No.
~
EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted.
AN ACT relating to prescription drugs; revising provisions relating
to the labeling of certain prescription drugs under certain
circumstances; and providing other matters properly
relating thereto.
Legislative Counsel’s Digest:
1 Existing law requires the labeling for a prescription drug to include the name of
2 the prescribing practitioner. (NRS 639.2801) This bill provides that upon request
3 from the prescribing practitioner, the labeling for a prescription for mifepristone,
4 misoprostol or their generic alternatives may instead include the name of the
5 prescribing health care practice instead of the name of the prescribing practitioner.
THE PEOPLE OF THE STATE OF NEVADA, REPRESENTED IN
SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS:
1 Section 1. NRS 639.2801 is hereby amended to read as
2 follows:
3 639.2801 Unless specified to the contrary in writing on the
4 prescription by the prescribing practitioner, all prescriptions filled
5 by any practitioner must be dispensed in a container to which is
6 affixed a label or other device which clearly shows:
7 1. The date.
8 2. The name, address and prescription serial number of the
9 practitioner who filled the prescription.
10 3. [The] Except as otherwise provided in this subsection, the
11 names of the prescribing practitioner and of the person for whom
12 prescribed. Upon request from the prescribing practitioner, an
-
*AB411_R1*
– 2 –
1 affixed label or device for a prescription for mifepristone,
2 misoprostol or their generic alternatives may include the name of
3 the prescribing health care practice instead of the name of the
4 prescribing practitioner.
5 4. The number of dosage units.
6 5. The symptom or purpose for which the drug is prescribed, if
7 included by the practitioner pursuant to NRS 639.2352.
8 6. Specific directions for use given by the prescribing
9 practitioner.
10 7. The expiration date of the effectiveness of the drug or
11 medicine dispensed, if that information is included on the original
12 label of the manufacturer of that drug or medicine. If the expiration
13 date specified by the manufacturer is not less than 1 year after the
14 date of dispensing, the practitioner may use a date that is 1 year after
15 the date of dispensing as the expiration date.
16 8. The proprietary or generic name of the drug or medicine as
17 written by the prescribing practitioner.
18 9. The strength of the drug or medicine.
19  The label must contain the warning:
20
21 Caution: Do not use with alcohol or nonprescribed drugs
22 without consulting the prescribing practitioner.
H
-
*AB411_R1*
[DELETED: (FBN.4AJ I O S A1,2  p r t p d EE a p o m pE o t g a m i i t n o tS 1  N 6 i h a t r a6  U s t t c i w o t a p m d i c t w1  T2  T n a a p s n o t3  [ U r f t p p a]
[DELETED: – l o d f a p f m p h c p i o t n o t4  T5  T6  S d f u g b t p7  T e d o t e o t d o8  T9  TC]


================================================================================

Raw Text:
(Reprinted with amendments adopted on May 19, 2025)
FIRST REPRINT A.B. 411
ASSEMBLY BILL NO. 411–ASSEMBLYMEMBER JAUREGUI
MARCH 12, 2025
____________
Referred to Committee on Health and Human Services
SUMMARY—Revises provisions relating to prescription drugs.
(BDR 54-1100)
FISCAL NOTE: Effect on Local Government: No.
Effect on the State: No.
~
EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted.
AN ACT relating to prescription drugs; revising provisions relating
to the labeling of certain prescription drugs under certain
circumstances; and providing other matters properly
relating thereto.
Legislative Counsel’s Digest:
1 Existing law requires the labeling for a prescription drug to include the name of
2 the prescribing practitioner. (NRS 639.2801) This bill provides that upon request
3 from the prescribing practitioner, the labeling for a prescription for mifepristone,
4 misoprostol or their generic alternatives may instead include the name of the
5 prescribing health care practice instead of the name of the prescribing practitioner.
THE PEOPLE OF THE STATE OF NEVADA, REPRESENTED IN
SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS:
1 Section 1. NRS 639.2801 is hereby amended to read as
2 follows:
3 639.2801 Unless specified to the contrary in writing on the
4 prescription by the prescribing practitioner, all prescriptions filled
5 by any practitioner must be dispensed in a container to which is
6 affixed a label or other device which clearly shows:
7 1. The date.
8 2. The name, address and prescription serial number of the
9 practitioner who filled the prescription.
10 3. [The] Except as otherwise provided in this subsection, the
11 names of the prescribing practitioner and of the person for whom
12 prescribed. Upon request from the prescribing practitioner, an
-
*AB411_R1*

– 2 –
1 affixed label or device for a prescription for mifepristone,
2 misoprostol or their generic alternatives may include the name of
3 the prescribing health care practice instead of the name of the
4 prescribing practitioner.
5 4. The number of dosage units.
6 5. The symptom or purpose for which the drug is prescribed, if
7 included by the practitioner pursuant to NRS 639.2352.
8 6. Specific directions for use given by the prescribing
9 practitioner.
10 7. The expiration date of the effectiveness of the drug or
11 medicine dispensed, if that information is included on the original
12 label of the manufacturer of that drug or medicine. If the expiration
13 date specified by the manufacturer is not less than 1 year after the
14 date of dispensing, the practitioner may use a date that is 1 year after
15 the date of dispensing as the expiration date.
16 8. The proprietary or generic name of the drug or medicine as
17 written by the prescribing practitioner.
18 9. The strength of the drug or medicine.
19  The label must contain the warning:
20
21 Caution: Do not use with alcohol or nonprescribed drugs
22 without consulting the prescribing practitioner.
H
-
*AB411_R1*

[DELETED: (FBN.4AJ I O S A1,2  p r t p d EE a p o m pE o t g a m i i t n o tS 1  N 6 i h a t r a6  U s t t c i w o t a p m d i c t w1  T2  T n a a p s n o t3  [ U r f t p p a]
[DELETED: – l o d f a p f m p h c p i o t n o t4  T5  T6  S d f u g b t p7  T e d o t e o t d o8  T9  TC]